博苑股份限售股解禁1963万股,募投项目投资额缩水近1亿元

Stock Performance - The company has 19.63 million restricted shares that will be unlocked for trading on December 10, 2025, which may increase market liquidity and potentially impact short-term stock price volatility [2] Project Progress - In August 2025, the company announced that the actual investment for two major IPO fundraising projects ("100 tons/year precious metal catalyst project" and "4100 tons/year high-end organic iodine and bromine new materials project") amounted to 141 million yuan, a decrease of nearly 100 million yuan from the planned investment of 241 million yuan. The company also proposed to use no more than 250 million yuan of idle raised funds and 500 million yuan of its own funds to purchase financial products, which has attracted market attention [3] Regulatory Situation - Data from the third-party environmental platform "Green Network" indicates that in the first quarter of 2025, the company's incinerator exhaust outlet recorded exceedances of carbon monoxide and nitrogen oxides. However, the company claimed in its 2025 semi-annual report that it achieved compliant emissions, raising concerns about the authenticity of its information disclosure [4]

Shandong Boyuan Pharmaceutical &Chemical Co.,Ltd-博苑股份限售股解禁1963万股,募投项目投资额缩水近1亿元 - Reportify